{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:34:04Z","timestamp":1790678044063,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.cca.2015.03.033","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T23:21:52Z","timestamp":1428276112000},"page":"155-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases"],"prefix":"10.1016","volume":"445","author":[{"given":"Thomas","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinhard","family":"Haltmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dieplinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2015.03.033_bb0005","first-page":"2442","article-title":"Biomarkers and diagnostics in HF","volume":"2013","author":"Gaggin","year":"1832","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2015.03.033_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10741-013-9396-5","article-title":"Clinical use of novel biomarkers in heart failure: towards personalized medicine","volume":"19","author":"Schmitter","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cca.2015.03.033_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cca.2014.10.046","article-title":"Which biomarkers do clinicians need for diagnosis and management of heart failure with reduced ejection fraction?","volume":"443","author":"Pouleur","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2015.03.033_bb0020","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2015.03.033_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2009.08.010","article-title":"Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma\u2014the Presage ST2 assay","volume":"409","author":"Dieplinger","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2015.03.033_bb0030","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.03.033_bb0035","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cca.2015.03.033_bb0040","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1183\/09031936.03.00078002","article-title":"COPD exacerbations: definitions and classifications","volume":"21","author":"Burge","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cca.2015.03.033_bb0045","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2015.03.033_bb0050","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","year":"1992","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cca.2015.03.033_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinbiochem.2012.09.014","article-title":"Performance characteristics of the ARCHITECT galectin-3 assay","volume":"46","author":"La'ulu","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2015.03.033_bb0060","series-title":"CLSI Document EP5-A","article-title":"Evaluation of precision performance of clinical chemistry devices; approved guideline","author":"Standards Institute Laborator Clinical","year":"1999"},{"key":"10.1016\/j.cca.2015.03.033_bb0065","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-013-2902-3","article-title":"Prognostic value of troponins in sepsis: a meta-analysis","volume":"39","author":"Bessi\u00e8re","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cca.2015.03.033_bb0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cca.2015.03.033_bb0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.coi.2014.03.004","article-title":"Interleukin 33: a switch-hitting cytokine","volume":"28C","author":"Villarreal","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"7S","key":"10.1016\/j.cca.2015.03.033_bb0080","doi-asserted-by":"crossref","first-page":"8B","DOI":"10.1016\/j.amjcard.2015.01.035","article-title":"Soluble ST2 \u2014 analytical considerations","volume":"115","author":"Mueller","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2015.03.033_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2014.09.021","article-title":"Soluble ST2 in heart failure","volume":"443C","author":"Dieplinger","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2015.03.033_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","article-title":"The regulation of inflammation by galectin-3","volume":"230","author":"Henderson","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cca.2015.03.033_bb0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1465-9921-14-136","article-title":"Galectin-3: its role in asthma and potential as an anti-inflammatory target","volume":"14","author":"Gao","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.cca.2015.03.033_bb0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2014.01.019","article-title":"Galectin-3 in cancer","volume":"431","author":"Song","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2015.03.033_bb0105","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1681\/ASN.2013050552","article-title":"Galectin-3 and new-onset CKD: marker or mediator?","volume":"24","author":"Ravani","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2015.03.033_bb0110","doi-asserted-by":"crossref","first-page":"946","DOI":"10.5966\/sctm.2013-0055","article-title":"Concise review: growth differentiation factor 15 in pathology: a clinical role?","volume":"2","author":"Corre","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.cca.2015.03.033_bb0115","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1373\/clinchem.2013.212811","article-title":"The story of growth differentiation factor 15: another piece of the puzzle","volume":"59","author":"Lindahl","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2015.03.033_bb0120","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.22196","article-title":"Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer","volume":"224","author":"Mimeault","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cca.2015.03.033_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/cc12765","article-title":"Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndrome","volume":"17","author":"Kempf","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.cca.2015.03.033_bb0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11897-012-0113-9","article-title":"Growth differentiation factor 15 in heart failure: an update","volume":"9","author":"Wollert","year":"2012","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cca.2015.03.033_bb0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cytogfr.2013.05.003","article-title":"The multiple facets of the TGF-\u03b2 family cytokine growth\/differentiation factor-15\/macrophage inhibitory cytokine-1","volume":"24","author":"Unsicker","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cca.2015.03.033_bb0140","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.clinbiochem.2010.02.002","article-title":"Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department","volume":"43","author":"Dieplinger","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2015.03.033_bb0145","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11606-008-0672-3","article-title":"The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study","volume":"23","author":"Thomsen","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cca.2015.03.033_bb0150","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ejheart.2007.06.004","article-title":"The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure","volume":"9","author":"Macchia","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cca.2015.03.033_bb0155","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1373\/clinchem.2012.190322","article-title":"Clinical and genetic correlates of growth differentiation factor 15 in the community","volume":"58","author":"Ho","year":"2012","journal-title":"Clin Chem"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115001771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898115001771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T17:52:36Z","timestamp":1537725156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898115001771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":31,"alternative-id":["S0009898115001771"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2015.03.033","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2015.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}